TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors. September 22, 2006